- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 211/94 - Atome d'oxygène, p.ex. N-oxyde de pipéridine
Détention brevets de la classe C07D 211/94
Brevets de cette classe: 239
Historique des publications depuis 10 ans
|
19
|
35
|
15
|
23
|
12
|
17
|
18
|
17
|
14
|
3
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| BASF SE | 19740 |
18 |
| Syngenta Participations AG | 4970 |
14 |
| Ecolab USA Inc. | 5190 |
12 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
10 |
| Helsinn Healthcare SA | 255 |
7 |
| Theravance Biopharma R&D IP, LLC | 550 |
7 |
| Amgen Inc. | 3779 |
6 |
| California Institute of Technology | 3884 |
6 |
| Celgene Corporation | 1412 |
6 |
| Adeka Corporation | 1333 |
5 |
| Celgene Quanticel Research, Inc. | 167 |
5 |
| TDK Corporation | 6306 |
4 |
| Ciba Holding Inc. | 177 |
4 |
| FMC Corporation | 910 |
4 |
| Syngenta Limited | 509 |
3 |
| Merck Patent GmbH | 5909 |
2 |
| Bayer Cropscience AG | 2241 |
2 |
| ABAC Therapeutics S.L. | 6 |
2 |
| Arizona Board of Regents, a Body Corporate of The State of Arizona Acting for and on Behalf of Arizona State University | 311 |
2 |
| Case Western Reserve University | 1727 |
2 |
| Autres propriétaires | 118 |